Automated cell counters are machines that automatically count cells. The sample is loaded into an automated cell counter and is forced through a small tube while the automated cell counter uses optical or electrical impedance sensors to count how many cells passed through the tube.
Danaher & Agilent Technologies, Inc.–are Notable Market Players in Automated Cell Counters Market
Market Dynamics
The growth of the market is attributed to the prevalence of infectious and chronic diseases drives the overall market growth. Additionally, the increase in drug discovery activities further enhance overall market growth during the forecast period.
Competitive Landscape
Market leaders operating in the automated cell counters market have undertaken various organic and inorganic growth strategies. The automated cell counters market majorly consists of players such as Eppendorf, Thermo Fischer Scientific, Countstar, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd, Chemometec A/S, ALIGNEDGENETICS, Beckman Coulter, Inc. (Danaher), Nanoentek, Olympus Corporation, MERCK KGaA, Sysmex Corporation, Agilent Technologies, Inc., Abbott, Nexcelom Bioscience LLC.
Several organic approaches, such as product launches, and expansion in the pharma ADMET testing market, have resulted in the growth of the market. Likewise, inorganic strategies such as mergers & acquisitions, and collaboration have helped the company to strengthen its revenue, which allows the company to hold a strong position in the market.
Below is the list of the growth strategies done by the players operating in the Automated Cell Counters market:
| Year | News |
| April-2022 | Beckman Coulter Life Sciences launches new CellMek SPS, a fully automated sample preparation system for clinical flow cytometry. The CellMek SPS builds on a rich variety of lab automation and incorporates features that enable lean workflows bolstering lab efficiency by streamlining and automating many outdated and manual preparation methods. The CellMek SPS is CE marked and FDA listed (Class I exempt) and will be available in countries that accept the CE mark as the basis for their country-specific registration |
| May-2022 | Beckman Coulter Life Sciences Launches AQUIOS STEM System to Provide a New Solution for Stem Cell Analysis. The AQUIOS STEM System enables complete automation that minimizes hands-on-time by 95% by reducing error-prone steps by 87.5% and decreases turn-around time. The system was designed with leading experts in the field of clinical CD34+ enumeration, and is a modular approach to automated and IVD-certified analysis of CD34+ hematopoietic cells and progenitor cells. |
| Aug-2019 | Agilent Technologies, Inc. announced acquisition of Biotek Instruments, a pioneer in design, manufacture, and distribution of innovative life science instrumentation. The acquisition results in expansion of Agilent’s presence and expertise in cell analysis and strengthen company’s position in the large and growing immuno-oncology and immunotherapy areas. |
| Jun-2019 | Agilent Technologies Inc. announced product launching of its first new product through acquisition of ACEA Biosciences. Agilent Technologies new product namely, “NovoCyte Advanteon Flow Cytometer” is one of the most sensitive cell analyzers available in the global market. |
| May-2022 | Agilent Technologies Inc. announced collaboration with APC Ltd., aiming to support automated process analysis through liquid chromatography (LC). The collaboration between the companies leverages their complementary strengths to develop specific workflows, which bridge the gap between the analytical and process solutions. |
